News & Press
WHOLE BIOME PRESENTS POSITIVE CLINICAL DATA AT ADA
Findings Demonstrate Clinical Efficacy of Microbiome Medical Food Product and Validate Unique Mechanism of Action.
SERIES B FUNDING ANNOUNCEMENT
Whole Biome Secures $35 Million in Series B Financing for Expansion of its Microbiome Discovery Platform and Commercialization of its First Product.
Whole Biome Eyes 2020 Launch of Medical Food for Diabetes
Whole Biome is preparing to launch its product early next year. Their work builds on the growing body of research on the gut microbiome.
Whole Biome CEO Colleen Cutcliffe talks vulnerabilities and what every early-stage founder needs to succeed.
Whole Biome Wins Buzz of Bio
“I am proud to feature these companies as our Buzz of BIO winners and provide them with the exposure and connections that come with presenting at the BIO Investor Forum” said Jim Greenwood, BIO President & CEO
Whole Biome Listed in “Top 20 Companies to Watch”
Among 180 companies attending the Bio Investor Forum, Whole Biome is seen as one of the top 20 companies to watch out for.
Whole Biome Interview Highlighted at BIO Conference
BIO Center interview with Colleen Cutcliffe on the microbiome space: challenges, promises and investment opportunities.
VLAB: Gut Feeling – Ventures into the Microbiome
Colleen Cutcliffe, Whole Biome CEO/Co-Founder, speaks at MIT/Stanford VLAB experts panel about the future of microbiome medicine.
Colleen Cutcliffe Featured on MendelsPod
Whole Biome's CEO and Co-Founder, Colleen Cutcliffe, was interviewed on MendelsPod and gives a background on the human microbiome.
My No-Soap, No-Shampoo, Bacteria-Rich Hygiene Experiment
Whole Biome, Inc. performed the sequencing and analysis that was featured in this New York Times Magazine article about natural skin probiotics.
Mayo Clinic and Whole Biome Announce Collaboration
Whole Biome, Inc. is co-developing microbiome targeted diagnostic testing with the Mayo Clinic...